Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, et al (1992) Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy. Neurology 42: 85–91.
Bach G (2001) Mucolipidosis type IV. Mol Genet Metab 73: 197–203.
Bajaj NPS, Waldmann A, Orrell B, Wood NW, Bhatia KP (2002) Familial adult onset of Krabbe’s disease resembling hereditary spastic paraplegia with normal neuroimaging. J Neurol Neurosurg Psychiatry 72: 635–638.
Barkhof F, Verrips A, Wesseling P, et al (2000) Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 217: 869–876.
Bataillard M, Richard P, Rumbach L, Vanier MT, Truttmann M (1997) Isolated spastic paraparesis disclosing Krabbe disease in adult age. Rev Neurol (Paris) 153: 347–350.
Baumann N, Turpin JC (2000) Adult-onset leukodystrophies. J Neurol 247: 751–759.
Baumann N, Masson M, Carreau V, Lefevre M, Hersckowitz N, Turpin JC (1991) Adult forms of metachromatic leukodystrophy: clinical and biochemical approach. Dev Neurosci 13: 211–215.
Baumgartner MR, Poll-The BT, Verhoeven NM, et al (1998) Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol 44: 720–730.
Berkhoff M, Weis J, Schroth G, Sturzenegger M (2001) Extensive white-matter changes in case of adult polyglucosan body disease. Neuroradiology 43: 234–236.
Bianchi MC, Tosetti M, Battini R (2003) Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. Am J Neuroradiol 24: 1958–1966.
Bischof F, Nagele T, Wanders RJ, Trefz FK, Melms A (2004) 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency in an adult with leukoencephalopathy. Ann Neurol 56: 727–730.
Bjorkhem I, Muri Boberg K, Leitersdorf E (2001) Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2961–2988.
Bosch EP, Hart MN (1978) Late adult-onset metachromatic leucodystrophy. Dementia and polyneuropathy in a 63-year-old-man. Arch Neurol 35: 475–477.
Boxer AL, Kramer JH, Johnston K, Goldman J, Finley R, Miller BL (2005) Executive dysfunction in hyperhomocystinemia responds to homocysteine lowering treatment. Neurology 64: 1431–1434.
Brady RO, Schiffmann R (2000) Clinical features of and recent advances in therapy for Fabry disease. JAMA 284: 2771–2775.
Deconinck N, Messaaoui A, Ziereisen F, et al (2007) Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency. Eur J Paediatr Neurol [E-pub ahead of print].
Eichler F, Mahmood A, Loes D, et al (2007) Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. Arch Neurol 64: 659–664.
Eriguchi M, Mizuta H, Kurohara K, et al (2006) 3-Methylglutaconic aciduria type I causes leukoencephalopathy of adult onset. Neurology 67: 1895–1896.
Farina L, Bizzi A, Finocchiaro G, et al (2000) MR imaging and proton MR spectroscopy in adult Krabbe disease. Am J Neuroradiol 21: 1478–1482.
Fellgiebel A, Muller MJ, Mazanek M, Baron K, Beck M, Stoeter P (2005) White matter lesion severity in male and female patients with Fabry disease. Neurology 23: 65: 600–602.
Filley CM, Kleinschmidt-DeMasters BK (2001) Toxic leukoencephalopathy. N Engl J Med 345: 425–432.
Finsterer J (2006) Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand 114: 217–238.
Fontaine B, Thenin JP, Viader F (2003) Gait disorders with insidious progression in a 60-year old woman. Rev Neurol (Paris) 159: 695–699.
Frei KP, Patronas NJ, Crutchfield KE, Altarescu G, Schiffmann R (1998) Mucolipidosis type IV: characteristic MRI findings. Neurology 51: 565–569.
Grunewald S, Champion MP, Leonard JV, Schaper J, Morris AA (2004) Biotinidase deficiency: a treatable leukoencephalopathy. Neuropediatrics 35: 211–216.
Harzer K, Knoblich R, Rolfs A, Bauer P, Eggers J (2002) Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease. Clin Chim Acta 317: 77–84.
Henderson RD, MacMillan JC, Bradfield JM (2003) Adult onset Krabbe disease may mimic motor neurone disease. J Clin Neurosci 10: 638–639.
Hirano M, Silvestri G, Blake DM, et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44: 721–727.
Hörster F, Surtees R, Hoffmann GF (2005) Disorders of intermediary metabolism: toxic leukoencephalopathies. J Inherit Metab Dis 28: 345–356.
Huck JH, Verhoeven NM, Struys EA, Salomons GS, Jakobs C, van der Knaap MS (2004) Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy. Am J Hum Genet 74: 745–751.
Janson CG, Kolodny EH, Zeng BJ, et al (2006) Mild-onset presentation of Canavan’s disease associated with novel G212A point mutation in aspartoacylase gene. Ann Neurol 59: 428–431.
Jaros E, Mahad DJ, Hudson G, et al (2007) Primary spinal cord neurodegeneration in Leber hereditary optic neuropathy. Neurology 69: 214–216.
Kasim S, Moo LR, Zschocke J, Jinnah HA (2001) Phenylketonuria presenting in adulthood as progressive spastic paraparesis with dementia. J Neurol Neurosurg Psychiatry 71: 795–797.
Kidd D, Nelson J, Jones F, et al (1998) Long-term stabilization after bone marrow transplantation in juvenile metachromatic leukodystrophy. Arch Neurol 55: 98–99.
Kiselyov K, Soyombo A, Muallem S (2007) TRPpathies. J Physiol 578: 641–653.
Krivit W, Shapiro EG, Peters C, et al (1998) Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 338: 1119–1126.
Kulkens S, Harting I, Sauer S, et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64: 2142–2144.
Kuriyama M, Fujiyama J, Yoshidome H, et al (1991) Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. J Neurol Sci 102: 225–232.
Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D (2005) White matter involvement in mitochondrial diseases. Mol Genet Metab 84: 127–136.
Lin DD, Crawford TO, Barker PB (2003) Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol 24: 33–41.
Lorincz MT, Rainier S, Thomas D, Fink JK (2005) Cerebrotendinous xanthomatosis. Possible higher prevalence than previously recognized. Arch Neurol 62: 1459–1463.
McCombe PA, McLaughlin DB, Chalk JB, Brown NN, McGill JJ, Pender MP (1992) Spasticity and white matter abnormalities in adult phenylketonuria. J Neurol Neurosurg Psychiatry 55: 359–361.
Menage P, Carreau V, Tourbah A, et al (1993) [Symptomatic heterozygotic adrenoleukodystrophy in adults. 10 cases] [In French]. Rev Neurol (Paris) 149: 445–454.
Mitsias P, Levine SR (1996) Cerebrovascular complications of Fabry’s disease. Ann Neurol 40: 8–17.
Moser AB, Rasmussen M, Naidu S, et al (1995) Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr 127: 13–22.
Moser HW, Mahmood A, Raymond GV (2007) X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 3: 140–151.
Ogier de Baulny H, Gerard M, Saudubray JM, Zittoun J (1998) Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr 157(Supplement 2): S77–83.
Owens WE, Okun MS (2004) Dystonia, tremor, and parkinsonism in a 54 year old man with 2-hydroxyglutaric aciduria. J Neurol Neurosurg Psychiatry 75: 1362–1363.
Rauschka H, Colsch B, Baumann N, et al (2006) Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology 67: 859–863.
Reis S, Sheffer RN, Merin S, Luder AS, Bach G (1993) Mucolipidosis type IV: a mild form with late onset. Am J Med Genet 47: 392–394.
Sabatelli M, Quaranta L, Madia F, et al (2002) Peripheral neuropathy with hypomyelinating features in adult-onset Krabbe’s disease. Neuromuscul Disord 12: 386–391.
Sakakibara R, Fukutake T, Arai K, Katayama K, Mori M, Hattori T (2001) Unilateral caudate head lesion stimulating brain tumour in X-linked adult onset adrenoleukodystrophy. J Neurol Neurosurg Psychiatry 70: 414–415.
Schiffmann R, van der Knaap MS (2004) The latest on leukodystrophies. Curr Opin Neurol 17: 187–192.
Schiffmann R, Dwyer NK, Lubensky IA, et al (1998) Constitutive achlorhydria in mucolipidosis type IV. Proc Natl Acad Sci U S A 95: 1207–1212.
Sedel F, Tourbah A, Baumann N, et al (2005) Adult onset leukodystrophies. Rev Neurol (Paris) 161: 916–931.
Sedel F, Lyon-Caen O, Saudubray JM (2007) Inborn errors of metabolism in adult neurology—a clinical approach focused on treatable diseases. Nat Clin Pract Neurol 3: 279–290.
Tészas A, Pfund Z, Morava E, et al (2006) Presenile cataract: consider cholestanol. Arch Ophthalmol 124: 1490–1492.
Thompson AJ, Tillotson S, Smith I, Kendall B, Moore SG, Brenton DP (1993) Brain MRI changes in phenylketonuria. Associations with dietary status. Brain 116: 811–821.
Tourbah A, Stievenart JL, Iba-Zizen MT, et al (1997) Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter. Arch Neurol 54: 586–592.
Turpin JC, Paturneau-Jouas M, Sereni C, Pluot M, Baumann N (1985) Adult disclosure of a case of familial adrenoleukodystrophy. Rev Neurol (Paris) 141: 289–295.
Van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV (2001) Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 49: 186–194.
Verrips A, Hoefsloot LH, Steenbergen GC, et al (2000) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 123: 908–919.
Von Figura K, Gieselmann V, Jaeken J (2001) Metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3695–3724.
Walk D, Kang SS, Horwitz A (1994) Intermittent encephalopathy, reversible nerve conduction slowing, and MRI evidence of cerebral white matter disease in methylenetetrahydrofolate reductase deficiency. Neurology 44: 344–347.
Weglage J, Oberwittler C, Marquardt T (2000) Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis 23: 83–84.
Wenger DA, Suzuki K, Suzuki Y, Suzuki K (2001) Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3669–3694.
Willemsen MA, Ijlst L, Steijlen PM, et al (2001) Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren–Larsson syndrome. Brain 124: 1426–1437.
Willemsen MA, Van Der Graaf M, Van Der Knaap MS, et al (2004) MR imaging and proton MR spectroscopic studies in Sjögren–Larsson syndrome: characterization of the leukoencephalopathy. Am J Neuroradiol 25: 649–657.
Wray SH, Provenzale JM, Johns DR, Thulborn KR (1995) MR of the brain in mitochondrial myopathy. AJNR Am J Neuroradiol 16: 1167–1173.
Ziemssen F, Sindern E, Schroder JM, et al (2000) Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease. Ann Neurol 47: 536–540.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4